Data / Form D filings / NEOVASC INC
NEOVASC INC: Form D filings
NEOVASC INC, a biotechnology company in Richmond, British Columbia, Canada, filed 2 Form D notices with the SEC between 2009 and 2011. The latest, on March 24, 2011, reports $26,215 sold of a $26,215 offering to 1 investor.
Find out what NEOVASC INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2135-13700 MAYFIELD PLACE, Richmond, British Columbia, Canada, 00000
- Phone
- (604) 270-4344
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1399708
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 24, 2011 | New notice | $26,215 | $26,215 | $0 | 1 | Mar 16, 2011 | sec.gov |
| May 4, 2009 | New notice | $2,576,588 | $1,503,010 | $1,073,578 | 11 | Apr 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BRIAN MCPHERSON | Executive Officer | |
| JANE HSIAO | Director | |
| PAUL GEYER | Executive Officer, Director | |
| ALEXEI MARKO | Executive Officer, Director | |
| DOUG JANZEN | Director | |
| CHRIS CLARK | Executive Officer | |
| STEVEN RUBIN | Director | |
| BOAZ LIFSCHITZ | Director | |
| WILLIAM O'NEILL | Director |
Every Form D from the week of Mar 21, 2011 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEOVASC INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.